Showing results (41-50 of 5,917) with videos related to
Sort By:
Pageof 592
Arthritis Research & Therapy|August 29, 2014
The window of opportunity: a relevant concept for axial spondyloarthritisPhilip C Robinson, Matthew A BrownArthritis Research & Therapy|August 30, 2014
A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritisMaria Greenwald, Leszek Szczepanski, Alastair Kennedy, et al.Arthritis Research & Therapy|July 17, 2013
Wnt and Rho GTPase signaling in osteoarthritis development and intervention: implications for diagnosis and therapyShouan Zhu, Huanhuan Liu, Yan Wu, et al.Arthritis Research & Therapy|June 9, 2012
Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J miceSara M Atkinson, Pernille A Usher, Peter H Kvist, et al.Arthritis Research & Therapy|June 9, 2012
Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activationSarita A Y Hartgring, Cynthia R Willis, Johannes W J Bijlsma, et al.Arthritis Research & Therapy|November 21, 2012
Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysisChun Lai Too, Shahnaz Murad, Jasbir Singh Dhaliwal, et al.Arthritis Research & Therapy|March 22, 2013
Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?Mike J L Peters, Michael T NurmohamedArthritis Research & Therapy|September 5, 2015
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS studyRaphaèle Seror, Gaétane Nocturne, Thierry Lazure, et al.Arthritis Research & Therapy|September 6, 2015
The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral discWilliam Mark Erwin, Leroi DeSouza, Martha Funabashi, et al.Arthritis Research & Therapy|September 11, 2015
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patientsJosef S Smolen, Ronald van Vollenhoven, Arthur Kavanaugh, et al.Pageof 592